Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R White

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Cancer|April 15, 1990
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association StudyD R White, B L Powell, J B Craig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF). A clinical trial of the Piedmont Oncology Association (POA)S K Shipp, H B Muss, M A Westrick, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphomaD V Jackson, H B Muss, F Richards, et al.
Cancer|February 15, 1985
A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim reportJ M Sterchi, H B Wells, L D Case, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical trial of folinic acid to reduce vincristine neurotoxicityD V Jackson, R A McMahan, E K Pope, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Journal of Neuro-Oncology|January 1, 1984
Improved tolerance of vincristine by glutamic acid. A preliminary reportD V Jackson, E K Pope, L D Case, et al.
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Cancer|April 15, 1990
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association StudyD R White, B L Powell, J B Craig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF). A clinical trial of the Piedmont Oncology Association (POA)S K Shipp, H B Muss, M A Westrick, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphomaD V Jackson, H B Muss, F Richards, et al.
Cancer|February 15, 1985
A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim reportJ M Sterchi, H B Wells, L D Case, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical trial of folinic acid to reduce vincristine neurotoxicityD V Jackson, R A McMahan, E K Pope, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Journal of Neuro-Oncology|January 1, 1984
Improved tolerance of vincristine by glutamic acid. A preliminary reportD V Jackson, E K Pope, L D Case, et al.
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.
Pageof 16